CONCERNING INCREASES IN NON-ALCOHOLIC FATTY LIVER DISEASE IN SOCIETY AND COLORECTAL CANCER IN THE HAWKESBURY, NSW REGION
With
Dr Kieran Longley, FRACP, MSc
Consultant Gastroenterologist & Hepatologist,
Blacktown & Mount Druitt Hospitals, Sydney &
The Centre for Gastrointestinal Health &
Macquarie Towns Specialist Centre, Richmond, NSW
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Richmond, Sydney | June 2026
Dr Kieran Longley is a Gastroenterologist and Hepatologist committed to providing comprehensive, patient-centred care across a broad spectrum of digestive and liver conditions. He completed his medical degree at the University of Tasmania before undertaking physician training at St Vincent’s Hospital Sydney. Furthering his academic and clinical expertise, he obtained a Master of Science in Internal Medicine from the University of Edinburgh.
Dr Longley completed advanced training in Gastroenterology and Hepatology across Campbelltown, Nepean, and Wollongong Hospitals. Following qualification as a gastroenterologist, he worked in regional and metropolitan centres throughout Australia, providing specialist care in areas of need and gaining extensive experience managing a diverse range of gastrointestinal disorders.
His clinical interests include general gastroenterology, hepatology, inflammatory bowel disease, and advanced endoscopic procedures. Dr Longley has undertaken specialised fellowship training in Advanced Endoscopy at Blacktown and Westmead Hospitals, focusing on mucosal resection and quality assurance in endoscopic practice. He is accredited by the Australian Conjoint Committee for Recognition of Training in Gastrointestinal Endoscopy (CCRTGE) in gastroscopy, colonoscopy, and video capsule endoscopy.
Known for his evidence-based and holistic approach, Dr Longley develops personalised management plans tailored to each patient’s individual needs. By combining advanced diagnostic and therapeutic techniques with clear communication and compassionate care, he helps patients achieve improved digestive health and long-term wellbeing.
Career Highlights
- Medical Degree, University of Tasmania
- Master of Science (Internal Medicine), University of Edinburgh
- Advanced Training in Gastroenterology and Hepatology across Campbelltown, Nepean, and Wollongong Hospitals
- CCRTGE accreditation in gastroscopy, colonoscopy, and video capsule endoscopy
- Advanced Endoscopy Fellowship at Blacktown and Westmead Hospitals
- Expertise in inflammatory bowel disease, hepatology, mucosal resection, enteroscopy, and capsule endoscopy
- Experience delivering specialist gastroenterology services in regional and metropolitan communities across Australia
- Fellow of The Royal Australasian College of Physicians
Source: Supplied
-
Using human skin hair follicles to treat Alzheimer’s disease
Professor Michael Valenzuela is a science opinion leader, innovator and creative thinker with a career-long commitment to the prevention and treatment of dementia.
Following that he completed graduate medicine and medical training at the Prince of Wales Hospital. In 2012, he established the Regenerative Neuroscience Group at the University of Sydney, and in 2017 became the university’s first Professor of Regenerative Medicine.
Professor Valenzuela’s group discovered a new cell type with potential for regenerative medicine, a rare neural precursor cell found deep within the human hair follicle. He is the main inventor on several related patents and is the Founder and Chief Scientific Officer of Skin2Neuron – a biotech company developing the first neurorestorative cell therapy for Alzheimer’s disease based on this work.
-
25 years of non-indexation of nuclear medicine impeding access & affordability
The President of the Australasian Association of Nuclear Medicine Specialists (AANMS), Associate Professor Sze Ting Lee spoke with Australian Health Journal about the following:
Usual levels of nuclear medicine services in Australia each year
Current levels of nuclear medicine services in Australia
How changing demographics in people moving to regional areas has impacted access to nuclear medicine services
The nuclear medicine workforce including trainees
The key recommendations from the pre-budget submissionIn the lead up to the Australian Federal Budget in May 2023, Australian Health Journal reached out to peak health industry bodies to hear about their priorities, either noted in pre-budget submissions lodged with Federal Government in January 2023 or in recent forums such as the Strengthening Medicare Taskforce.
-
National Cancer Plan activates Australian Comprehensive Cancer Network
The landscape of cancer care in Australia is set to transform with the Australian Government launch in May 2024 of the Australian Comprehensive Cancer Network (ACCN) at the Innovations Showcase event, hosted by Cancer Australia in Sydney, Australia.
The ACCN is a nationally integrated system of cancer care, aimed at enhancing patient experiences and outcomes through coordinated and equitable access, by linking to comprehensive cancer services across Australia. Anchored by Comprehensive Cancer Centres (CCCs), the ACCN strives to deliver evidence-driven prevention, diagnosis, treatment, and support to all Australians affected by cancer.
